Insider Trading & Ownership of Michael James Newman

Location
Jerusalem, Israel
Summary
The estimated net worth of Michael James Newman is at least $205,180 dollars as of 29 Dec 2025. Michael James Newman is the CSO and Director, Director of Indaptus Therapeutics, Inc. and owns shares of Indaptus Therapeutics, Inc. (INDP) stock worth about $205.2K.
Signature
/s/ Michael Newman
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Michael James Newman and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Michael James Newman has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $205,180.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Indaptus Therapeutics, Inc. ($205,180).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Michael James Newman

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
INDP Indaptus Therapeutics, Inc. CSO and Director, Director $205,180 22 Dec 2025

Insider Transactions Reported by Michael James Newman:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored